Similar articles

• Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy.

  Carruthers J, Carruthers A, Tezel A, Kraemer J, Craik L. Carruthers J, et al. Dermatol Surg. 2010 Nov;36 Suppl 3:1886-92. doi: 10.1111/j.1524-4725.2010.01778.x. Dermatol Surg. 2010. PMID: 20969666 Clinical Trial.
• [Full face approach. Not just treating wrinkles, but the entire face]].

  Bublak R. Bublak R. MMW Fortschr Med. 2013 Apr 4;155(6):24. doi: 10.1007/s15006-013-0483-2. MMW Fortschr Med. 2013. PMID: 23700691 German. No abstract available.
• Blinded evaluation of the effects of hyaluronic acid filler injections on first impressions.

  Dayan SH, Arkins JP, Gal TJ. Dayan SH, et al. Dermatol Surg. 2010 Nov;36 Suppl 3:1866-73. doi: 10.1111/j.1524-4725.2010.01737.x. Dermatol Surg. 2010. PMID: 20969664 Clinical Trial.
• Facial rejuvenation using botulinum toxin A: review and updates.

  Vartanian AJ, Dayan SH. Vartanian AJ, et al. Facial Plast Surg. 2004 Feb;20(1):11-9. doi: 10.1055/s-2004-822954. Facial Plast Surg. 2004. PMID: 15034809 Review.
• [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].

  Gassia V. Gassia V. Ann Dermatol Venereol. 2009 May;136 Suppl 4:S146-51. doi: 10.1016/S0151-9638(09)74543-0. Ann Dermatol Venereol. 2009. PMID: 19576482 Review. French.